Pharming Group N.V. (PHAR)
NASDAQ: PHAR · IEX Real-Time Price · USD
8.51
-0.24 (-2.74%)
At close: Jul 19, 2024, 4:00 PM
8.94
+0.43 (5.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pharming Group Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Pharming Group stock has a target of 37, which predicts an increase of 334.78% from the current stock price of 8.51.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Pharming Group is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +334.78% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +334.78% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +334.78% | Aug 3, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $36 → $40 | Buy | Maintains | $36 → $40 | +370.04% | Mar 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +334.78% | Mar 27, 2023 |
Financial Forecast
Revenue This Year
303.37M
from 245.32M
Increased by 23.66%
Revenue Next Year
349.64M
from 303.37M
Increased by 15.25%
EPS This Year
0.00
from -0.16
EPS Next Year
0.03
from 0.00
Increased by 1,030.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 331.1M | 388.5M | 497.0M | 551.2M | 514.6M |
| Avg | 303.4M | 349.6M | 413.1M | 445.3M | 432.6M |
| Low | 274.7M | 293.3M | 308.4M | 322.8M | 342.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 35.0% | 28.1% | 42.1% | 33.4% | 15.6% |
| Avg | 23.7% | 15.3% | 18.2% | 7.8% | -2.8% |
| Low | 12.0% | -3.3% | -11.8% | -21.9% | -23.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.02 | 0.08 | 0.14 | 0.09 | 0.13 |
| Avg | 0.00 | 0.03 | 0.07 | 0.09 | 0.13 |
| Low | -0.02 | -0.01 | 0.01 | 0.08 | 0.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 2,835.9% | 369.1% | 24.9% | 52.2% |
| Avg | - | 1,030.0% | 139.8% | 22.5% | 49.3% |
| Low | - | - | -66.3% | 16.6% | 42.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.